Company Profile
Palatin Technologies, Inc. Stock Price, News & Analysis
- Ticker:
- PTN
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
7.87 USD (-0.88%)
Close
Last updated: August 6, 2026
24.7M USD
Market cap
Why the stock is moving
As of Aug 6, 2026, PTN closed down 0.88% at $7.87. No new same-company headline was identified in the current news window.
Company overview
Business overview
Palatin Technologies is a specialty pharmaceutical company focused on receptor biology and niche therapeutic areas. Its story has centered on a small set of programs and the difficulty of sustaining a durable commercial or development base.
Geographic Base and Sector Classification
Palatin is headquartered in the United States and listed on NYSE American. It sits in specialty pharma rather than broad biotech.
Business Model Characteristics
The company depends on clinical progress, commercial execution, and capital discipline. Investors typically watch pipeline updates and strategic positioning.
Position Within the Biotechnology Landscape
Palatin occupies a small specialty-pharma niche within healthcare. It is a catalyst-sensitive story where a narrow set of programs can dominate the valuation.
Future catalysts
Palatin’s catalysts are obesity and women’s-health programs, especially any development or partnering step that keeps the pipeline relevant. The company still needs a clearer path to value.
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Palatin Technologies, Inc. (PTN)?
Palatin Technologies, Inc. (PTN) most recently closed at 7.87 USD, a -0.88% move versus the previous session.
What is the market cap of Palatin Technologies, Inc. (PTN)?
Palatin Technologies, Inc. currently has a market capitalization of 24.7M USD on BioPharmSignal.
What does Palatin Technologies, Inc. do?
Palatin Technologies is a specialty pharmaceutical company focused on receptor biology and niche therapeutic areas. Its story has centered on a small set of programs and the difficulty of sustaining a durable commercial or development base.
On which exchange is PTN stock listed?
Palatin Technologies, Inc. (PTN) is associated with NASDAQ, United States, Biopharma.
What is Palatin?
Palatin’s catalysts are obesity and women’s-health programs, especially any development or partnering step that keeps the pipeline relevant.
Which conditions is Palatin Technologies, Inc. targeting with Palatin?
Palatin Technologies, Inc. is associated with obesity based on its company overview and current catalyst commentary.
How does Palatin Technologies, Inc. describe recent progress with Palatin?
Palatin’s catalysts are obesity and women’s-health programs, especially any development or partnering step that keeps the pipeline relevant.
What is Technologies?
Palatin Technologies is a specialty pharmaceutical company focused on receptor biology and niche therapeutic areas.